Dorzolamide/timolol
From Self-sufficiency
| Combination of | |
|---|---|
| Dorzolamide | Carboanhydrase inhibitor |
| Timolol | Beta blocker |
| Clinical data | |
| Routes of administration | eye drops |
| Identifiers | |
| ATC code | S01ED51 (WHO) |
Dorzolamide/timolol eyedrops (trade name Cosopt) are used for lowering pressure in the eye to normal levels, and a treatment for glaucoma. The drug is a combination of two chemicals: dorzolamide hydrochloride and timolol maleate. It gained Food and Drug Administration (FDA) approval in April 1998, and is supplied by Merck.
External links
| 40px | This medical treatment-related article is a stub. You can help ssf by expanding it. |
| 40x30px | This eye article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Drugs that are a combination of chemicals
- Infobox drug tracked parameters
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Ophthalmology
- Pages with broken file links
- Medical treatment stubs
- Eye stubs
- 2Fix
